The utility of ANCA and ASCA in inflammatory bowel disease
β Scribed by Dr. Stephan R. Targan
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 270 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The short-chain fatty acid butyrate, which is mainly produced in the lumen of the large intestine by the fermentation of dietary fibers, plays a major role in the physiology of the colonic mucosa. It is also the major energy source for the colonocyte. Numerous studies have reported that butyrate met
Background: Despite scattered case reports, the prevalence of inflammatory bowel disease (IBD) in patients with autoimmune pancreatitis (AIP) is unknown. We sought to better characterize the putative association between the conditions. Methods: Medical records of 71 patients meeting accepted criteri
Extraintestinal manifestations of inflammatory bowel disease (IBD) are common. Clinically significant renal/ urologic complications occur in 10-1 5% of patients with IBD. In this article, we review the incidence, pathogenesis, diagnosiq, and management of the various renalhrologic complications. In